SCHEMBL29346540

SCHEMBL29346540

CC1=CCC(C)CN1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.38
GPR119 Q8TDV5 4/20 0.35
KDM1A O60341 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LIPE Q05469 1/20 0.33
HSD11B1 P28845 1/20 0.33
KMT2A Q03164 1/20 0.33
NAMPT P43490 1/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
PTPN2 P17706 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25915727 1.00 NR1H2 (0.38) NR1H2GPR119KDM1ACHRM2CHRM1
SCHEMBL25322423 0.79 GPR119 (0.41) NR1H2GPR119KDM1AKMT2APTPN2
SCHEMBL25322429 0.79 GPR119 (0.41) NR1H2GPR119KDM1AKMT2APTPN2
SCHEMBL29324819 0.77 GPR119 (0.34) NR1H2GPR119KDM1AHSD11B1
SCHEMBL25908047 0.77 GPR119 (0.34) NR1H2GPR119KDM1AHSD11B1
SCHEMBL24365214 0.77 GPR119 (0.32) NR1H2GPR119KDM1AMAPTHSD11B1
SCHEMBL24365544 0.77 PIK3CD (0.39) GPR119
SCHEMBL31145156 0.76 MAPT (0.33) GPR119KDM1ACHRM2CHRM1CHRM3
SCHEMBL29081837 0.76 HSD11B1 (0.33) NR1H2GPR119KDM1ALIPEHSD11B1
SCHEMBL24364304 0.76 ESR2 (0.36) GPR119KDM1AMAPTNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228478-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 NR1H2 408/4885GPR119 216/4885KDM1A 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.